The New York Times Company Reports 2022 Second-Quarter Results

NEW YORK--(BUSINESS WIRE)-- The New York Times Company (NYSE: NYT) announced today that its second-quarter 2022 financial results are available on The New York Times Company’s investor relations website at investors.nytco.com.

As previously announced, The New York Times Company will host its earnings conference call today at 8:00 a.m. E.T. to discuss these financial results. A live webcast of the earnings conference call will be available at investors.nytco.com. Participants can pre-register for the telephone conference at https://dpregister.com/sreg/10167677/f300447b9b, which will generate dial-in instructions allowing participants to bypass an operator at the time of the call. Alternatively, to access the call without pre-registration, dial 844-413-3940 (in the U.S.) or 412-858-5208 (international callers).

An archive of the webcast will be available beginning about two hours after the call at investors.nytco.com. An audio replay will be available at 877-344-7529 (in the U.S.) and 412-317-0088 (international callers) beginning approximately two hours after the call until 11:59 p.m. E.T. on Wednesday, August 17. The passcode is 1596359.

About The New York Times Company

The New York Times Company (NYSE: NYT) is a trusted source of quality, independent journalism whose mission is to seek the truth and help people understand the world. With more than 9 million subscribers accounting for more than 10 million subscriptions across a diverse array of print and digital products — from news to cooking to games to sports — The Times Company has evolved from a local and regional news leader into a diversified media company with curious readers, listeners and viewers around the globe. Follow news about the company at NYTCo.com.

This press release can be downloaded from www.nytco.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220802005891/en/

Investors: Harlan Toplitzky, 212-556-7775, [email protected]
Media: Danielle Rhoades Ha, 212-556-8719, [email protected]

Source: The New York Times Company

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
• GOOD WORKS, GIVING, AND GLAMOUR SHINE AT NORTH SHORE ANIMAL LEAGUE AMERICA'S RESCUE GALA CELEBRATING ANIMAL RESCUE AND ADOPTION